EMJ had the pleasure of interviewing leading specialists in the field of breast cancer: Javier Cortés, International Breast Cancer Center, Quiron Group, Barcelona, Spain, and Giuseppe Curigliano, European Institute of Oncology (IEO), Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rionero in Vulture, and University of Milano, Milan, Italy. Both experts in the management of human epidermal growth factor receptor 2-positive metastatic breast cancer (HER2+ MBC), Cortés and Curigliano offered their perspectives on the current issues in the treatment of this disease.
Latest articles
All articles
